IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Werner Krause

USPTO Granted Patents = 16 


Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 114(Granted Patents)


Company Filing History:

goldMedal16 out of 1,384 
 
Schering Aktiengesellschaft
 patents

Years Active: 1992-2003

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 6638913 - Concentrated injection and infusion solution for intravenous administration (2003-10-28),
2. 6254850 - Metal complexes, suitable for use in diagnosis and therapy (2001-07-03),
3. 6156873 - Bismuth dendrimers, processes for their preparation, and their use as (2000-12-05),
4. 6040432 - Metal complexes, of DTPA derivatives suitable for use in diagnosis and (2000-03-21),
5. 5896439 - Process for avoiding radiation injury in diagnostic radiology (1999-04-20),
6. 5885548 - Multiply substituted DTPA derivatives and their metal complexes, and (1999-03-23),
7. 5874422 - Use of non-steroidal anti-inflammatory agents to improve the (1999-02-23),
8. 5853699 - Use of tetra azacycle complexes as x-ray diagnostic agents for the liver (1998-12-29),
9. 5814301 - Use of prostacyclin derivatives to prevent or to treat disorders of the (1998-09-29),
10. 5756066 - Iodine-containing peptides (1998-05-26),
11. 5746995 - DTPA derivatives substituted in a novel way, their metal complexes, and (1998-05-05),
12. 5695737 - Dimeric DTPA derivatives, their metal complexes and pharmaceutical (1997-12-09),
13. 5672335 - Use of metal complexes as liver and gallbladder X-ray diagnostic agents (1997-09-30),
14. 5593660 - Cascade polymers with iodoaromatic compounds (1997-01-14),
15. 5350750 - .beta.-carboline-3-hydroxyalkylcarboxylic acid ester derivatives, (1994-09-27),

Title: **Inventor Spotlight: Werner Krause**

Introduction

Werner Krause, an innovative inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals with a total of 16 patents to his name. His work not only showcases his deep understanding of medicinal chemistry but also emphasizes his commitment to advancing healthcare solutions.

Latest Patents

Among his latest inventions, Krause has developed a concentrated injection and infusion solution for intravenous administration. This innovative solution incorporates additives that help avoid or mitigate acute or delayed hypersensitivity reactions. He has also designed metal complexes that are suitable for use in both diagnosis and therapy. This particular invention relates to diethylenetriaminepentaacetic acid derivatives and their complexes, containing elements with atomic numbers ranging from 20 to 83. These pharmaceutical agents can function as contrast media and antidotes, highlighting their multifunctional therapeutic potential.

Career Highlights

Werner Krause is currently affiliated with Schering Aktiengesellschaft, a reputable pharmaceutical company known for its focused approach towards specialized healthcare solutions. Throughout his career, Krause has demonstrated an exceptional ability to bridge the gap between chemical innovation and practical medical applications.

Collaborations

Krause has collaborated with esteemed colleagues such as Gabriele Schuhmann-Giampieri and Franz-Karl Maier. Together, they contribute to a collaborative environment that fosters the development of groundbreaking solutions in the pharmaceutical arena.

Conclusion

Werner Krause's contributions to medicine and innovation through his patents reflect his dedication to improving patient outcomes. His commitment to research and development positions him as a significant figure in the pharmaceutical industry, inspiring future innovations that aim to enhance the quality of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…